Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kircheis

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Gene Therapy|February 4, 1999
The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cellsM Ogris, P Steinlein, M Kursa, et al.
Cancer Letters|November 25, 2000
Xenogenization by tetanus toxoid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomesT Felzmann, M Buchberger, M Jechlinger, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
International Journal of Pharmaceutics|June 11, 1999
Liposomes as cytokine-supplement in tumor cell-based vaccinesM L van Slooten, R Kircheis, F J Koppenhagen, et al.
European Cytokine Network|July 1, 1992
Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cellsR Kircheis, J Milleck, V G Korobko, et al.
The Journal of Gene Medicine|September 1, 2001
Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivoL Wightman, R Kircheis, V Rössler, et al.
Gene Therapy|June 13, 2001
Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic applicationR Kircheis, L Wightman, A Schreiber, et al.
Immunology|July 1, 1992
Biological activity of mutants of human tumour necrosis factor-alphaR Kircheis, J Milleck, V G Korobko, et al.
The Journal of Gene Medicine|March 30, 2000
Polycation-based DNA complexes for tumor-targeted gene delivery in vivoR Kircheis, S Schüller, S Brunner, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2009
Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approachA Nechansky, O H J Szolar, P Siegl, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Gene Therapy|February 4, 1999
The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cellsM Ogris, P Steinlein, M Kursa, et al.
Cancer Letters|November 25, 2000
Xenogenization by tetanus toxoid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomesT Felzmann, M Buchberger, M Jechlinger, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
International Journal of Pharmaceutics|June 11, 1999
Liposomes as cytokine-supplement in tumor cell-based vaccinesM L van Slooten, R Kircheis, F J Koppenhagen, et al.
European Cytokine Network|July 1, 1992
Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cellsR Kircheis, J Milleck, V G Korobko, et al.
The Journal of Gene Medicine|September 1, 2001
Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivoL Wightman, R Kircheis, V Rössler, et al.
Gene Therapy|June 13, 2001
Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic applicationR Kircheis, L Wightman, A Schreiber, et al.
Immunology|July 1, 1992
Biological activity of mutants of human tumour necrosis factor-alphaR Kircheis, J Milleck, V G Korobko, et al.
The Journal of Gene Medicine|March 30, 2000
Polycation-based DNA complexes for tumor-targeted gene delivery in vivoR Kircheis, S Schüller, S Brunner, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2009
Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approachA Nechansky, O H J Szolar, P Siegl, et al.
Pageof 3